Cargando…
The histone demethylase KDM3A, and its downstream target MCAM, promote Ewing Sarcoma cell migration and metastasis
Ewing Sarcoma is the second most common solid pediatric malignant neoplasm of bone and soft tissue. Driven by EWS/Ets, or rarely variant, oncogenic fusions, Ewing Sarcoma is a biologically and clinically aggressive disease with a high propensity for metastasis. However, the mechanisms underpinning E...
Autores principales: | Sechler, Marybeth, Parrish, Janet K., Birks, Diane K., Jedlicka, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519422/ https://www.ncbi.nlm.nih.gov/pubmed/28319067 http://dx.doi.org/10.1038/onc.2017.44 |
Ejemplares similares
-
KDM3A/Ets1/MCAM axis promotes growth and metastatic properties in Rhabdomyosarcoma
por: Sobral, Lays Martin, et al.
Publicado: (2020) -
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth
por: Parrish, Janet K., et al.
Publicado: (2018) -
KDM5A and PHF2 positively control expression of pro-metastatic genes repressed by EWS/Fli1, and promote growth and metastatic properties in Ewing sarcoma
por: McCann, Tyler S., et al.
Publicado: (2020) -
Increased mitochondrial function downstream from KDM5A histone demethylase rescues differentiation in pRB-deficient cells
por: Váraljai, Renáta, et al.
Publicado: (2015) -
MiR-193b, downregulated in Ewing Sarcoma, targets the ErbB4 oncogene to inhibit anchorage-independent growth
por: Moore, Colin, et al.
Publicado: (2017)